High Tide, NuLeaf Join New U.S. Council to Shape Cannabinoid Care Policy
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
High Tide ( (TSE:HITI) ) has shared an update.
High Tide and its U.S. hemp-derived CBD subsidiary NuLeaf Naturals have joined the newly formed National Compassionate Care Council as founding members, aligning with other healthcare-focused cannabis organizations dedicated to improving patient access to cannabinoid therapies. The move positions High Tide to help shape emerging U.S. medical cannabis standards and evidence-based policy, particularly as federal initiatives around cannabis rescheduling and potential Medicare reimbursement for hemp-derived products gain momentum, with potential operational and market implications for its American CBD businesses.
By contributing its experience from brands such as NuLeaf Naturals and FAB CBD, High Tide aims to support efforts to modernize healthcare standards, prioritize product quality and patient outcomes, and expand access to safe cannabinoid treatments nationwide. Participation in the council underscores the company’s strategy to deepen its influence in U.S. healthcare policy for cannabinoids, which could strengthen its industry positioning and benefit patients, regulators and its own hemp-derived CBD subsidiaries as regulatory frameworks evolve.
The most recent analyst rating on (TSE:HITI) stock is a Sell with a C$3.00 price target. To see the full list of analyst forecasts on High Tide stock, see the TSE:HITI Stock Forecast page.
Spark’s Take on TSE:HITI Stock
According to Spark, TipRanks’ AI Analyst, TSE:HITI is a Neutral.
The score is driven primarily by weakened financial performance (2025 loss resurgence and materially higher leverage) and bearish technicals (below key moving averages with negative MACD and very weak RSI/Stochastic). Positive operating/free cash flow provides some support, but valuation is constrained by ongoing losses and no stated dividend yield.
To see Spark’s full report on TSE:HITI stock, click here.
More about High Tide
High Tide Inc. is a community-grown, retail-forward cannabis enterprise with diversified operations spanning recreational retail, medical distribution and e-commerce for accessories and hemp-derived CBD products. Its Canna Cabana chain is Canada’s largest cannabis retailer with 219 locations and about 12% domestic market share, while German unit Remexian Pharma imports and wholesales medical cannabis from 19 countries. NuLeaf Naturals, founded in 2014 in Denver, is a leading U.S. cannabinoid company producing high-potency, cGMP-manufactured formulations sold online and through select brick-and-mortar outlets across the country.
Average Trading Volume: 96,786
Technical Sentiment Signal: Sell
Current Market Cap: C$298.7M
Learn more about HITI stock on TipRanks’ Stock Analysis page.
